Research

Successful Treatment of Anti-Caspr2 Syndrome by Interleukin 6 Receptor Blockade Through Tocilizumab February 27, 2021

https://jamanetwork.com/journals/jamaneurology/fullarticle/1697440

Learn more
Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype February 27, 2021

https://academic.oup.com/brain/article/136/10/3151/327490

Learn more
Binding deficits in memory following medial temporal lobe damage in patients with voltage-gated potassium channel complex antibody-associated limbic encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722347/

Learn more
Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897696/

Learn more
Insights from LGI1 and CASPR2 potassium channel complex antibody subtyping February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895328/

Learn more
Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806918/

Learn more
Quantitative FLAIR analysis indicates predominant affection of the amygdala in antibody-associated limbic encephalitis February 27, 2021

https://onlinelibrary.wiley.com/doi/abs/10.1111/epi.12320

Learn more
Autoimmune encephalitis: Recent updates and emerging challenges February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/24246947

Learn more
Pediatric inflammatory brain diseases: a diagnostic approach February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/25050924

Learn more
Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013813/

Learn more